NEFL and amyotrophic lateral sclerosis: When examining plasma NfL's ability to differentiate AD dementia from various non‐AD neurodegenerative disorders in two multicenter cohorts (Ashton et al, 2021a), AUCs ranged from 0.53 (PD/PDD) to 0.88 (ALS).